← Leaderboards
Anka Veleva
Clave Biodesign, Inc.
$1,506,000
Attributed
$1,506,000
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2013–20$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NSF$1,506,000 · 4
By mechanism
—$1,506,000 · 4
Top collaborators
No co-investigators on record.
Grant awards (4)
SBIR Phase II: Lignin-Based Formulations for Efficient and Sustainable Control of Plant Pathogens$800,000
· FY2020 · TIP · contact PI
SBIR Phase I: COVID-19-impermeable high-performance porous coatings for respiratory personal protective equipment$256,000
· FY2020 · TIP · contact PI
SBIR Phase I: Lignin-Based Formulations for Efficient and Sustainable Control of Plant Pathogens$225,000
· FY2018 · TIP · contact PI
STTR Phase I: Novel Molecularly Targeted Tracer for Specific and Sensitive Imaging of Cancer$225,000
· FY2013 · TIP · contact PI